GlassScriptPhysician profile
Mary Strek
NPI 1497818918
$51,799.55
in general payments reported to CMS, 2019-2025
11 companies · $6,912 in 2025
The $6,912 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $744 · 2021: $6,298 · 2022: $1,592 · 2023: $661 · 2024: $13K · 2025: $6,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,320 · Food and Beverage: $489 · Travel and Lodging: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,907.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,319.87 |
| Food and Beverage | $489.34 |
| Travel and Lodging | $388.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $27,182.58 | 2019-2024 | Ofev |
| E.R. Squibb & Sons, L.L.C. | $10,725.00 | 2024-2025 | |
| Boehringer Ingelheim Pharma Gmbh & Co.Kg | $10,467.33 | 2019 | |
| Boehringer Ingelheim International Gmbh | $3,189.28 | 2021-2024 | Ofev |
| Electromed, INC. | $110.24 | 2019-2025 | Smartvest |
| Genentech USA, INC. | $50.34 | 2019 | |
| Philips North America LLC | $37.94 | 2024 | (Ak6) Vest Therapy |
| Inogen, INC. | $20.04 | 2025 | |
| Insmed, INC. | $16.80 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Strek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.